Neurode Secures $10M to Revolutionize ADHD Care with a Drug-Free, At-Home Wearable Solution

We are thrilled to announce that Neurode has successfully raised $10,000,000 in our latest funding round—a monumental step forward in revolutionizing ADHD treatment and monitoring. At Neurode, our mission is to empower individuals with ADHD by providing a wearable headband that offers a drug-free, innovative solution to managing symptoms in just 20 minutes a day, all from the comfort of home. This new influx of capital will accelerate our vision to make ADHD treatment more accessible and personalized, enhancing the quality of life for millions. With these funds, we will bolster research and development efforts, fine-tune our wearable device’s technology, and expand clinical trials to ensure that our product is not only effective but also safe and user-friendly. In addition, a portion of the investment will be directed toward scaling our manufacturing capabilities and setting up comprehensive support systems to enhance customer experience as we enter broader markets. Our approach combines cutting-edge neuroscience with state-of-the-art wearable technology, aiming to disrupt traditional treatment modalities by offering a sustainable and non-pharmaceutical alternative. The confidence shown by our investors reinforces our commitment to innovation in mental health technology and underscores the transformative potential of our product. As we continue our journey toward reshaping ADHD care, we remain dedicated to our core mission: alleviating the challenges faced by individuals with ADHD while enabling them to achieve their full potential. We look forward to sharing more updates on our progress and celebrating this new era of mental health innovation with our community and supporters.